0.00Open0.30Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover4320.63%IV36.31%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.1495Delta0.0742Gamma24.60Leverage Ratio-9.8107Theta0.0000Rho-3.68Eff Leverage0.0002Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$